David M. Knott’s Ibere Pharmaceuticals IBER Stock Holding History

David M. Knott’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$349K	Hold	36,000	–	–	0.13%	81
2021 Q2	$348K	Buy	+36,000	New	+$350K	0.12%	86

Other funds holding IBER

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SCC

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

David M. Knott's IBER Position: Q3 2021 in Review

David M. Knott held its Ibere Pharmaceuticals (IBER) position steady in Q3 2021 at 36,000 shares worth $349K. The position accounts for 0.13% of the portfolio, ranked #81.

David M. Knott first reported a position in IBER in Q2 2021 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold IBER as of Q3 2021.

David M. Knott held 36,000 shares of Ibere Pharmaceuticals worth $349K as of Q3 2021.
David M. Knott left its Ibere Pharmaceuticals share count unchanged in Q3 2021.
Ibere Pharmaceuticals made up 0.13% of David M. Knott's portfolio in Q3 2021, its #81 holding.
David M. Knott first reported a position in Ibere Pharmaceuticals in Q2 2021 and has held it in 2 quarters since.
38 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.